Sapporo Clinical Laboratory, Inc.

  • Market Cap: Micro Cap
  • Industry: Retailing
  • ISIN: JP3321100004
JPY
1,960.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
5,171.11
5,066.96
4,855.42
5,278.98
4,997.72
4,999.25
4,829.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,171.11
5,066.96
4,855.42
5,278.98
4,997.72
4,999.25
4,829.62
Raw Material Cost
3,533.23
3,595.14
3,375.60
3,651.20
3,405.43
3,557.67
3,386.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.83
1.51
1.58
1.67
1.73
1.70
1.89
Selling and Distribution Expenses
1,345.95
1,383.98
1,315.32
1,424.08
1,353.02
1,342.97
1,320.79
Other Expenses
-0.18
-0.15
-0.16
-0.17
-0.17
-0.17
0.01
Total Expenditure (Excl Depreciation)
4,879.18
4,979.12
4,690.92
5,075.28
4,758.45
4,900.64
4,709.75
Operating Profit (PBDIT) excl Other Income
291.90000000000003
87.8
164.5
203.70000000000002
239.3
98.6
119.9
Other Income
5.43
6.75
-8.49
8.36
2.97
6.19
-21.23
Operating Profit (PBDIT)
466.42
255.29
306.08
358.25
376.05
233.39
245.13
Interest
1.83
1.51
1.58
1.67
1.73
1.70
1.89
Exceptional Items
0.55
0.00
-8.64
0.00
0.00
0.00
-6.81
Gross Profit (PBDT)
1,637.87
1,471.82
1,479.82
1,627.78
1,592.29
1,441.58
1,442.66
Depreciation
169.06
160.71
150.08
146.20
133.81
128.59
146.50
Profit Before Tax
296.09
93.08
145.78
210.38
240.52
103.10
89.94
Tax
90.96
42.59
54.02
70.05
75.63
42.08
31.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
203.02
47.80
97.03
144.74
165.89
56.52
68.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
203.02
47.80
97.03
144.74
165.89
56.52
68.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.11
2.69
-5.28
-4.40
-1.00
4.50
-9.79
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
205.12
50.49
91.76
140.34
164.89
61.02
58.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
11,398.08
11,147.54
11,153.90
11,037.97
10,876.32
10,741.65
10,936.65
Earnings per share (EPS)
65.07
15.32
31.1
46.39
53.17
17.9
20.47
Diluted Earnings per share
65.07
15.32
31.1
46.39
53.17
17.9
20.47
Operating Profit Margin (Excl OI)
5.65%
1.73%
3.39%
3.86%
4.79%
1.97%
2.48%
Gross Profit Margin
9.0%
5.01%
6.09%
6.75%
7.49%
4.63%
4.9%
PAT Margin
3.93%
0.94%
2.0%
2.74%
3.32%
1.13%
1.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 2.05% vs 4.36% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 306.14% vs -44.99% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 85.51% vs -21.01% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 20.00% vs -6.25% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Sapporo Clinical Laboratory, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
5,171.11
13,933.16
-8,762.05
-62.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,171.11
13,933.16
-8,762.05
-62.89%
Raw Material Cost
3,533.23
12,284.53
-8,751.30
-71.24%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.83
27.90
-26.07
-93.44%
Selling and Distribution Expenses
1,345.95
1,164.01
181.94
15.63%
Other Expenses
-0.18
-2.79
2.61
93.55%
Total Expenditure (Excl Depreciation)
4,879.18
13,448.54
-8,569.36
-63.72%
Operating Profit (PBDIT) excl Other Income
291.93
484.62
-192.69
-39.76%
Other Income
5.43
30.25
-24.82
-82.05%
Operating Profit (PBDIT)
466.42
733.92
-267.50
-36.45%
Interest
1.83
27.90
-26.07
-93.44%
Exceptional Items
0.55
-3.88
4.43
114.18%
Gross Profit (PBDT)
1,637.87
1,648.63
-10.76
-0.65%
Depreciation
169.06
219.06
-50.00
-22.82%
Profit Before Tax
296.09
483.08
-186.99
-38.71%
Tax
90.96
192.24
-101.28
-52.68%
Provisions and contingencies
0
0
0.00
Profit After Tax
203.02
280.01
-76.99
-27.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
203.02
280.01
-76.99
-27.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
2.11
10.84
-8.73
-80.54%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
205.12
290.85
-85.73
-29.48%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
11,398.08
14,817.47
-3,419.39
-23.08%
Earnings per share (EPS)
65.07
74.35
-9.28
-12.48%
Diluted Earnings per share
65.07
74.35
-9.28
-12.48%
Operating Profit Margin (Excl OI)
5.65%
3.48%
0.00
2.17%
Gross Profit Margin
9.00%
5.04%
0.00
3.96%
PAT Margin
3.93%
2.01%
0.00
1.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 517.11 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 2.05% vs 4.36% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 3.47% vs 1.17% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.51 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 306.14% vs -44.99% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 24.38% vs -23.97% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.10 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 85.51% vs -21.01% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 23.56% vs 8.05% in Sep 2024

Quarterly - Interest
Interest 0.18 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 20.00% vs -6.25% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.88% vs -10.53% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.65%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024